HER Signaling May Explain Chemo Resistance in Lung Cancer

Increased levels of human epidermal growth factor receptor (HER) may be the key to chemotherapy resistance in non–small-cell lung cancer (NSCLC), according to a new study.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news